Exploring targeted therapy of osteosarcoma using proteomics data

References

• SettakornJLekawanvijitSArpornchayanonOSpectrum of bone tumors in Chiang Mai University Hospital, Thailand according to WHO classification 2002: a study of 1,001 casesJ Med Assoc Thai200689678078716850677
   PubMedGoogle Scholar
• FriebeleJCPeckJPanXAbdel-RasoulMMayersonJLOsteosarcoma: a meta-analysis and review of the literatureAm J Orthop (Belle Mead NJ)2015441254755326665241
   PubMedGoogle Scholar
• AllisonDCCarneySCAhlmannERA meta-analysis of osteosarcoma outcomes in the modern medical eraSarcoma2012201270487222550423
   PubMedGoogle Scholar
• MooreDDLuuHHOsteosarcomaCancer Treat Res2014162659225070231
   PubMedGoogle Scholar
• MoriarityBSOttoGMRahrmannEPA sleeping beauty forward genetic screen identifies new genes and pathways driving osteosarcoma development and metastasisNat Genet201547661562425961939
   PubMed Web of Science ®Google Scholar
• ChenXBahramiAPappoARecurrent somatic structural variations contribute to tumorigenesis in pediatric osteosarcomaCell Rep20147110411224703847
   PubMed Web of Science ®Google Scholar
• HanashSTaguchiAThe grand challenge to decipher the cancer proteomeNat Rev Cancer201010965266020733593
   PubMedGoogle Scholar
• ShuklaHDMahmoodJVujaskovicZIntegrated proteo-genomic approach for early diagnosis and prognosis of cancerCancer Lett20153691283626276717
   PubMedGoogle Scholar
• LaranceMLamondAIMultidimensional proteomics for cell biologyNat Rev Mol Cell Biol201516526928025857810
   PubMed Web of Science ®Google Scholar
• Gene OntologyCGene Ontology Consortium: going forwardNucleic Acids Res201543Database issueD1049D105625428369
   PubMedGoogle Scholar
• MiHPoudelPMuruganujanACasagrandeJTThomasPDPANTHER version 10: expanded protein families and functions, and analysis toolsNucl Acids Res2015
   Google Scholar
• Huang daWShermanBTLempickiRASystematic and integrative analysis of large gene lists using DAVID bioinformatics resourcesNat Protoc200941445719131956
   PubMed Web of Science ®Google Scholar
• TermglinchanVWanichnopparatWSuwanwongseKCandidate cancer-targeting agents identified by expression-profiling arraysOnco Targets Ther2013644745823637543
   PubMed Web of Science ®Google Scholar
• PruksakornDTeeyakasemPKlangjorhorJOverexpression of KH-type splicing regulatory protein regulates proliferation, migration, and implantation ability of osteosarcomaInt J Oncol201649310
   Google Scholar
• SpreaficoAFredianiBCapperucciCA proteomic study on human osteoblastic cells proliferation and differentiationProteomics20066123520353216705754
   PubMedGoogle Scholar
• GuoQCShenJNJinSComparative proteomic analysis of human osteosarcoma and SV40-immortalized normal osteoblastic cell linesActa Pharmacol Sin200728685085817506944
   PubMed Web of Science ®Google Scholar
• FolioCMoraMIZalacainMProteomic analysis of chemonaive pediatric osteosarcomas and corresponding normal bone reveals multiple altered molecular targetsJ Proteome Res2009883882388819492781
   PubMedGoogle Scholar
• LiuXZengBMaJWanCComparative proteomic analysis of osteosarcoma cell and human primary cultured osteoblastic cellCancer Invest200927334535219212829
   PubMed Web of Science ®Google Scholar
• ZhangZZhangLHuaYComparative proteomic analysis of plasma membrane proteins between human osteosarcoma and normal osteoblastic cell linesBMC Cancer20101020620470422
   PubMedGoogle Scholar
• PosthumaDeboerJPiersmaSRPhamTVSurface proteomic analysis of osteosarcoma identifies EPHA2 as receptor for targeted drug deliveryBr J Cancer201310982142215424064975
   PubMed Web of Science ®Google Scholar
• GemollTEppingFHeinrichLIncreased cathepsin D protein expression is a biomarker for osteosarcomas, pulmonary metastases and other bone malignanciesOncotarget2015618165171652626203049
   PubMedGoogle Scholar
• HuaYJiaXSunMPlasma membrane proteomic analysis of human osteosarcoma and osteoblastic cells: revealing NDRG1 as a marker for osteosarcomaTumour Biol20113251013102121706236
   PubMedGoogle Scholar
• YuDKahenECubittCLIdentification of synergistic, clinically achievable, combination therapies for osteosarcomaSci Rep201551699126601688
   PubMed Web of Science ®Google Scholar
• GrignaniGPalmeriniEDileoPA phase II trial of sorafenib in relapsed and unresectable high-grade osteosarcoma after failure of standard multimodal therapy: an Italian Sarcoma Group studyAnn Oncol201223250851621527590
   PubMed Web of Science ®Google Scholar
• GrignaniGPalmeriniEFerraresiVSorafenib and everolimus for patients with unresectable high-grade osteosarcoma progressing after standard treatment: a non-randomised phase 2 clinical trialLancet Oncol20151619810725498219
   PubMed Web of Science ®Google Scholar
• KuboTPiperdiSRosenblumJPlatelet-derived growth factor receptor as a prognostic marker and a therapeutic target for imatinib mesylate therapy in osteosarcomaCancer2008112102119212918338812
   PubMed Web of Science ®Google Scholar
• GobinBMoriceauGOryBImatinib mesylate exerts anti-proliferative effects on osteosarcoma cells and inhibits the tumour growth in immunocompetent murine modelsPLoS One201493e9079524599309
   PubMedGoogle Scholar
• BondMBernsteinMLPappoAA phase II study of imatinib mesylate in children with refractory or relapsed solid tumors: a Children’s Oncology Group studyPediatr Blood Cancer200850225425817262795
   PubMed Web of Science ®Google Scholar
• ChughRWathenJKMakiRGPhase II multicenter trial of imatinib in 10 histologic subtypes of sarcoma using a Bayesian hierarchical statistical modelJ Clin Oncol200927193148315319451433
   PubMed Web of Science ®Google Scholar
• ThamilselvanVMenonMThamilselvanSCarmustine enhances the anticancer activity of selenite in androgen-independent prostate cancer cellsCancer Manag Res2012438339523204869
   PubMedGoogle Scholar
• KuoCCLiuTWChenLTCombination of arsenic trioxide and BCNU synergistically triggers redox-mediated autophagic cell death in human solid tumorsFree Radic Biol Med201151122195220922001324
   PubMedGoogle Scholar
• ScotlandiKBaldiniNOlivieroMExpression of Met/hepatocyte growth factor receptor gene and malignant behavior of musculoskeletal tumorsAm J Pathol19961494120912198863670
   PubMed Web of Science ®Google Scholar
• PataneSAvnetSColtellaNMET overexpression turns human primary osteoblasts into osteosarcomasCancer Res20066694750475716651428
   PubMedGoogle Scholar
• PaulSMMytelkaDSDunwiddieCTHow to improve R&D productivity: the pharmaceutical industry’s grand challengeNat Rev Drug Discov20109320321420168317
   PubMed Web of Science ®Google Scholar
• GuptaSCSungBPrasadSWebbLJAggarwalBBCancer drug discovery by repurposing: teaching new tricks to old dogsTrends Pharmacol Sci201334950851723928289
   PubMed Web of Science ®Google Scholar
• ZhuSYanXXiangZDingHFCuiHLeflunomide reduces proliferation and induces apoptosis in neuroblastoma cells in vitro and in vivoPLoS One201388e7155523977077
   PubMedGoogle Scholar
• AlhefdhiABurkeJFRedlichAKunnimalaiyaanMChenHLeflunomide suppresses growth in human medullary thyroid cancer cellsJ Surg Res2013185121221623816245
   PubMedGoogle Scholar
• KoYJSmallEJKabbinavarFA multi-institutional phase ii study of SU101, a platelet-derived growth factor receptor inhibitor, for patients with hormone-refractory prostate cancerClin Cancer Res20017480080511309325
   PubMedGoogle Scholar
• ElbazHAStueckleTATseWRojanasakulYDinuCZDigitoxin and its analogs as novel cancer therapeuticsExp Hematol Oncol201211423210930
   PubMedGoogle Scholar
• GalloMSapioLSpinaANaviglioDCalogeroANaviglioSLactic dehydrogenase and cancer: an overviewFront Biosci (Landmark Ed)2015201234124925961554
   PubMed Web of Science ®Google Scholar
• XiongYWuSDuQWangAWangZIntegrated analysis of gene expression and genomic aberration data in osteosarcoma (OS)Cancer Gene Ther2015221152452926427513
   PubMedGoogle Scholar
• DurnaliAAlkisNCangurSPrognostic factors for teenage and adult patients with high-grade osteosarcoma: an analysis of 240 patientsMed Oncol201330362423749307
   PubMed Web of Science ®Google Scholar
• MazurekSPyruvate kinase type M2: a key regulator of the metabolic budget system in tumor cellsInt J Biochem Cell Biol201143796998020156581
   PubMed Web of Science ®Google Scholar
• ChanetonBGottliebERocking cell metabolism: revised functions of the key glycolytic regulator PKM2 in cancerTrends Biochem Sci201237830931622626471
   PubMed Web of Science ®Google Scholar
• ZhouCFLiXBSunHPyruvate kinase type M2 is upregulated in colorectal cancer and promotes proliferation and migration of colon cancer cellsIUBMB Life201264977578222807066
   PubMed Web of Science ®Google Scholar
• WangLYLiuYPChenLGPyruvate kinase M2 plays a dual role on regulation of the EGF/EGFR signaling via E-cadherin-dependent manner in gastric cancer cellsPLoS One201386e6754223840737
   PubMed Web of Science ®Google Scholar
• HasilikANeufeldEFBiosynthesis of lysosomal enzymes in fibroblasts. Synthesis as precursors of higher molecular weightJ Biol Chem198025510493749456989821
   PubMedGoogle Scholar
• BenesPVetvickaVFusekMCathepsin D–many functions of one aspartic proteaseCrit Rev Oncol Hematol2008681122818396408
   PubMed Web of Science ®Google Scholar
• SueharaYKondoTFujiiKProteomic signatures corresponding to histological classification and grading of soft-tissue sarcomasProteomics20066154402440916807943
   PubMed Web of Science ®Google Scholar
• KawaiAKondoTSueharaYKikutaKHirohashiSGlobal protein-expression analysis of bone and soft tissue sarcomasClin Orthop Relat Res200846692099210618535868
   PubMedGoogle Scholar
• LiYLiangQWenYQComparative proteomics analysis of human osteosarcomas and benign tumor of boneCancer Genet Cytogenet201019829710620362224
   PubMedGoogle Scholar
• RaoUNHoodBLJones-LaughnerJMSunMConradsTPDistinct profiles of oxidative stress-related and matrix proteins in adult bone and soft tissue osteosarcoma and desmoid tumors: a proteomics studyHum Pathol201344572573323063503
   PubMedGoogle Scholar
• BonaAPapaiZMaaszGMass spectrometric identification of ancient proteins as potential molecular biomarkers for a 2000-year-old osteogenic sarcomaPLoS One201491e8721524475253
   PubMedGoogle Scholar
• FloresRJLiYYuAA systems biology approach reveals common metastatic pathways in osteosarcomaBMC Syst Biol201265022640921
   PubMedGoogle Scholar
• ChenXYangTTZhouYProteomic profiling of osteosarcoma cells identifies ALDOA and SULT1A3 as negative survival markers of human osteosarcomaMol Carcinog201453213814422949271
   PubMedGoogle Scholar
• TangJShenLYangQZhangCOverexpression of metadherin mediates metastasis of osteosarcoma by regulating epithelial-mesenchymal transitionCell Prolif201447542743425174891
   PubMed Web of Science ®Google Scholar
• AraiKSakamotoRKubotaDKondoTProteomic approach toward molecular backgrounds of drug resistance of osteosarcoma cells in spheroid culture systemProteomics201313152351236023712969
   PubMed Web of Science ®Google Scholar
• KubotaDMukaiharaKYoshidaATsudaHKawaiAKondoTProteomics study of open biopsy samples identifies peroxiredoxin 2 as a predictive biomarker of response to induction chemotherapy in osteosarcomaJ Proteomics20139139340423911960
   PubMed Web of Science ®Google Scholar
• IzbickaECamposDMartyJCarrizalesGMangoldGTolcherAMolecular determinants of differential sensitivity to docetaxel and paclitaxel in human pediatric cancer modelsAnticancer Res2006263A1983198816827133
   PubMedGoogle Scholar
• KangJHParkKKLeeISProteome analysis of responses to ascochlorin in a human osteosarcoma cell line by 2-D gel electrophoresis and MALDI-TOF MSJ Proteome Res20065102620263117022633
   PubMedGoogle Scholar
• ChangYCParkWHMinKSKimTKimCHKangJHProteome profiling of U2OS cell line in response to a prenylphenol antibiotic isolated from a phytopathogenic fungusBiol Pharm Bull20083191696170318758062
   PubMedGoogle Scholar
• XieXBYinJQWenLLCritical role of heat shock protein 27 in bufalin-induced apoptosis in human osteosarcomas: a proteomic-based researchPLoS One2012710e4737523091618
   PubMed Web of Science ®Google Scholar
• KansaraMTengMWSmythMJThomasDMTranslational biology of osteosarcomaNat Rev Cancer2014141172273525319867
   PubMed Web of Science ®Google Scholar
• SauAFilomeniGPezzolaSTargeting GSTP1-1 induces JNK activation and leads to apoptosis in cisplatin-sensitive and -resistant human osteosarcoma cell linesMol Biosyst201284994100622068640
   PubMedGoogle Scholar
• KlevebringDFagerbergLLundbergEEmanuelssonOUhlenMLundebergJAnalysis of transcript and protein overlap in a human osteosarcoma cell lineBMC Genomics20101168421126332
   PubMedGoogle Scholar
• KirkwoodKJAhmadYLaranceMLamondAICharacterization of native protein complexes and protein isoform variation using size-fractionation-based quantitative proteomicsMol Cell Proteomics201312123851387324043423
   PubMed Web of Science ®Google Scholar
• GemeiMCorboCD’AlessioFDi NotoRVentoRDel VecchioLSurface proteomic analysis of differentiated versus stem-like osteosarcoma human cellsProteomics201313223293329724106197
   PubMedGoogle Scholar
• LaranceMAhmadYKirkwoodKJLyTLamondAIGlobal subcellular characterization of protein degradation using quantitative proteomicsMol Cell Proteomics201312363865023242552
   PubMedGoogle Scholar
• NiforouKMAnagnostopoulosAKVougasKKittasCGorgoulisVGTsangarisGTThe proteome profile of the human osteosarcoma U2OS cell lineCancer Genomics Proteomics200851637818359981
   PubMedGoogle Scholar
• LiGZhangWZengHAn integrative multi-platform analysis for discovering biomarkers of osteosarcomaBMC Cancer2009915019445706
   PubMedGoogle Scholar
• LiYDangTAShenJIdentification of a plasma proteomic signature to distinguish pediatric osteosarcoma from benign osteochondromaProteomics20066113426343516673437
   PubMedGoogle Scholar
• LiYDangTAShenJPlasma proteome predicts chemotherapy response in osteosarcoma patientsOncol Rep201125230331421165584
   PubMedGoogle Scholar
• SavitskayaYARico-MartinezGLinares-GonzalezLMSerum tumor markers in pediatric osteosarcoma: a summary reviewClin Sarcoma Res20122922587902
   PubMedGoogle Scholar
• JinSShenJNGuoQC2-D DIGE and MALDI-TOF-MS analysis of the serum proteome in human osteosarcomaProteomics Clin Appl20071327228521136678
   PubMedGoogle Scholar
• KanehisaMGotoSKEGG: Kyoto encyclopedia of genes and genomesNucleic Acids Res200028273010592173
   PubMed Web of Science ®Google Scholar
• NishimuraDBiotech Software & Internet ReportNYMary Ann Liebert, Inc200123117120
   Google Scholar
• TermglinchanVWanichnopparatWSuwanwongseKCandidate cancer-targeting agents identified by expression-profiling arraysOnco Targets Ther2013644745823637543
   PubMed Web of Science ®Google Scholar
• WishartDSKnoxCGuoACDrugBank: a comprehensive resource for in silico drug discovery and explorationNucleic Acids Res200634Database issueD668D67216381955
   PubMed Web of Science ®Google Scholar